Skip to main content

La radiothérapie dans les cancers ovariens

  • Chapter
Les cancers ovariens

Part of the book series: Abord clinique ((ONCOLPRAT))

  • 319 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Références

  1. Delclos L, Dembo AJ (1973) Tumors of the ovary. In: Fletcher GH (ed) Texbook of radiotherapy Third Edition. Lea & Febiger, Philadelphie, p 834

    Google Scholar 

  2. Klaassen D, Shelley W, Starreveld A et al. (1988) Early stage ovarian cancer: a randomized clinical trial comparing whole abdominal radiotherapy, Melphalan, and intraperitoneal chromic phosphate: a National Cancer Institute of Canada Trials Group Report. J Clin Oncol 6: 1254–63

    CAS  PubMed  Google Scholar 

  3. Vergote IB, Winderen M, DeVos LN et al. (1993) Intraperitoneal radioactive phosphorus therapy in ovarian carcinoma. Cancer 71: 2250–60

    CAS  PubMed  Google Scholar 

  4. Goodman A, Bornstein L, Ball H et al. (1994) Chronic phosphate therapy in carcinoma of the ovary. J Am Coll Surg 179: 401–6

    CAS  PubMed  Google Scholar 

  5. Tharp M, Hornback NB (1994) Complications associated with intraperitoneal 32P. Gynecol Oncol 53: 170–5

    Article  CAS  PubMed  Google Scholar 

  6. Spanos WJ, Day T, Abner A et al. (1992) Complications in the use of intra-abdominal 32P for ovarian carcinoma. Gynecol Oncol 45: 243–7

    Article  PubMed  Google Scholar 

  7. Rogers L, Varia M, Halle J et al. (1993) 32P following negative second look laparotomy for epithelial ovarian cancer. Gynecol Oncol 50: 141–6

    Article  CAS  PubMed  Google Scholar 

  8. Peters WA, Smith MR, Cain JM et al. (1992) Intraperitoneal P-32 is not effective consolidation therapy after a negative second look laparotomy for epithelial carcinoma of the ovary. Gynecol Oncol 47: 146–9

    Article  PubMed  Google Scholar 

  9. Spencer TR, Marks RD, Fenn JO et al. (1989) Intraperitoneal P-32 after negative second look laparotomy in ovarian carcinoma. Cancer 63: 2434–7

    PubMed  Google Scholar 

  10. Young RC, Walton LA, Ellenberg SS et al. (1990) Adjuvant therapy in stage I and stage II. epithelial ovarian cancer. Results of two prospctive randomized trials. N Engl J Med. 322:1021–7

    CAS  PubMed  Google Scholar 

  11. Young R, Nieberg R et al. (1999) Randomized clinical trial of adjuvant treatment of women with early (FIGO I-IIA high risk) ovarian cancer-GOG #95. Int J Gynecol Cancer 9: 11 (abstr. A33)

    Google Scholar 

  12. Vergote IB, Vergote de Vos LN, Abeler VM et al. (1992) Randomized trial comparing cisplatin with radioactive phosphorus or whole-abdomen irradiation as adjuvant treatment of ovarian cancer. Cancer 69: 741–9

    CAS  PubMed  Google Scholar 

  13. Standards, options, recommandations. Tumeurs épithéliales malignes de l’ovaire (vol. 4) (1998) Fédération nationale des centres de lutte contre le cancer (ed). John Libbey Eurotext, Montrouge

    Google Scholar 

  14. Lhommé C, Ray-Coquard I, Guastalla JP et al. (2004) Recommandations pour la pratique clinique Standards, Options et Recommandations 2003 pour le traitement médical de première ligne des patientes atteintes de tumeurs épithéliales malignes de l’ovaire, mise à jour (rapport abrégé). Bull Cancer 91: 609–20

    PubMed  Google Scholar 

  15. Dembo AJ (1983) Radiation therapy in the management of ovarian cancer. Clin Obstet Gynaecol 10: 261–78

    CAS  PubMed  Google Scholar 

  16. Fletcher GH, Shukovsky LJ (1975) The interplay of radiocurability and tolerance in the irradiation of human cancers. J Radiol Electrol Med Nucl 56: 383–400

    CAS  PubMed  Google Scholar 

  17. Dembo AJ (1992) Epithelial ovarian cancer: the role of radiotherapy. Int J Radiat Oncol Biol Phys 22: 835–45

    CAS  PubMed  Google Scholar 

  18. Haie C, Pejovic-Lenfant MH, George M et al. (1989) Whole abdominal irradiation following chemotherapy in patients with minimal residual disease after second look surgery in ovarian carcinoma. Int J Radiat Oncol Biol Phys 17: 15–9

    CAS  PubMed  Google Scholar 

  19. Delouche G, Valinta D, Bachelot F et al. (1981) Radiothérapie des cancers épithéliaux de l’ovaire. Irradiation totale de l’abdomen par champs orthogonaux. J Eur Radiother 2: 103–17

    Google Scholar 

  20. Thomas L, Pigneux J, Chauvergne J et al. (1993) Irradiation abdomino-pelvienne des cancers ovariens par 4 faisceaux orthogonaux: technique tolérance, complications. Bull Cancer Radiother 80: 241–8

    Google Scholar 

  21. Duthoy W, De Gersem W, Vergote K, et al. (2003) Whole abdominopelvic radiotherapy (WAPRT) using intensity-modulated arc therapy (IMAT): first clinical experience. Int J Radiat Oncol Biol Phys 57: 1019–32

    Article  PubMed  Google Scholar 

  22. Thomas L, Pigneux J, Chauvergne J et al. (1994) Evaluation of whole abdominal irradiation in ovarian carcinoma with a four orthogonal fields technique. Int J Radiat Oncol Biol Phys 30: 1083–90

    CAS  PubMed  Google Scholar 

  23. Fyles AW, Dembo AJ, Bush RS et al. (1992) Analysis of complications in patients treated with abdomino-pelvic radiation therapy for ovarian carcinoma. Int J Radiat Oncol Biol Phys 22: 847–51

    CAS  PubMed  Google Scholar 

  24. Whelan TJ, Dembo AJ, Bush RS et al. (1992) Complications of whole abdominal and pelvic radiotherapy following chemotherapy for advanced ovarian cancer. Int J Radiat Oncol Biol Phys 22: 853–8

    CAS  PubMed  Google Scholar 

  25. Van Bunningen B, Bouma J, Kooijman C et al. (1988) Total abdominal irradiation in stage I and II carcinoma of the ovary. Radiother Oncol 11: 305–10

    PubMed  Google Scholar 

  26. Firat S, Murray K, Erickson B (2003) High-dose whole abdominal and pelvic irradiation for treatment of ovarian carcinoma: long-term toxicity and outcomes. Int J Radiat Oncol Biol Phys 57: 201–7

    Article  PubMed  Google Scholar 

  27. Sell A, Bertelsen K, Andersen JE et al. (1990) Randomized study of whole-abdomen irradiation versus pelvic irradiation plus cyclophosphamide in treatment of early ovarian cancer. Gynecol Oncol 37: 367–73

    Article  CAS  PubMed  Google Scholar 

  28. Chiara S, Conte P, Franzone P et al. (1994) High-risk early-stage ovarian cancer. Randomized clinical trial comparing cisplatin plus cyclophosphamide versus whole abdominal radiotherapy. Am J Clin Oncol 17: 72–6

    CAS  PubMed  Google Scholar 

  29. Kojs Z, Glinski B, Reinfuss M et al. (2001) Résultat d’un essai randomisé comparant une radiothérapie abdomino-pelvienne postopératoire et une chimiothérapie postopératoire dans les cancers de l’ovaire précoces. Cancer Radiother 5: 5–11

    CAS  PubMed  Google Scholar 

  30. Colombo N, Guthrie D, Chiari S et al. (2003) International Collaborative Ovarian Neoplasm trial 1: a randomized trial of adjuvant chemotherapy in women with early-stage ovarian cancer. J Natl Cancer Inst 95: 125–32

    PubMed  Google Scholar 

  31. Trimbos JB, Vergote I, Bolis G et al. (2003) Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm trial. J Natl Cancer Inst 95: 113–25

    CAS  PubMed  Google Scholar 

  32. Einhorn N, Trope C, Ridderheim M et al. (2003) A systematic overview of radiation therapy effects in ovarian cancer. Acta Oncol 42: 562–6

    PubMed  Google Scholar 

  33. Menczer J, Ben-Baruch G, Modan M et al. (1989) Intraperitoneal cisplatin chemotherapy versus abdominopelvic irradiation in varian carcinoma patients after second look laparotomy. Cancer 63: 1509–13

    CAS  PubMed  Google Scholar 

  34. Podczaski E, Manetta A, Kaminski P et al. (1990) Survival of patients with ovarian epithelial carcinomas after second look laparotomy. Gynecol Oncol 36: 43–7

    Article  CAS  PubMed  Google Scholar 

  35. Creasman WT, Gall S, Bundy BN et al. (1989) Second-look laparotomy in the patient with minimal residual stage III ovarian cancer (a Gynecologic Oncology Group Study). Gynecol Oncol 35: 378–82

    CAS  PubMed  Google Scholar 

  36. Rubin SC, Hoskins WJ, Saigo PE et al. (1991) Prognostic factors for recurrence following negative second look laparotomy in ovarian cancer patients treated with platinum-based chemotherapy. Gynecol Oncol 42: 137–41

    CAS  PubMed  Google Scholar 

  37. Franchin G, Tumolo S, Scarabelli C et al. (1991) Whole abdomen radiation therapy after a short chemotherapy course and second look laparotomy in advanced ovarian cancer. Gynecol Oncol 1991; 41: 206–11

    CAS  Google Scholar 

  38. Thomas GM (1993) Is there a role for consolidation or salvage radiotherapy after chemotherapy in advanced epithelial ovarian cancer? Gynecol Oncol 51: 97–103

    Article  CAS  PubMed  Google Scholar 

  39. Bruzzone M, Repetto L, Chiara S et al. (1990) Chemotherapy versus radiotherapy in the management of ovarian cancer patients with pathological complete response or minimal residual disease at second look. Gynecol Oncol 38: 392–5

    Article  CAS  PubMed  Google Scholar 

  40. Lambert HE, Rustin GJS, Gregory WM et al. (1993) A randomized trial comparing singleagent carboplatin with carboplatin followed by radiotherapy for advanced ovarian cancer: a North Thames Ovary Group Study. J Clin Oncol 11: 440–8

    CAS  PubMed  Google Scholar 

  41. Mangioni C, Epis A, Vassena L et al. (1987) Radiotherapy versus chemotherapy as second line treatment of minimal residual disease in advanced epithelial ovarian cancer. Proc International Gynecologic Cancer Society, 49

    Google Scholar 

  42. Sorbe B on behalf of the Swedish-Norgewian Ovarian Cancer Study Group (2003) Consolidation treatment of advanced (FIGO stage III) ovarian carcinoma in complete surgical remission after induction chemotherapy: a randomized, controlled, clinical trial comparing whole abdominal radiotherapy, chemotherapy, and no further treatment. Int J Gynecol Cancer 13: 278–86

    Google Scholar 

  43. Debby A, Levy T, Hayat H et al. (2004) Whole-abdomen, single-dose consolidation radiotherapy in patients with pathologically confirmed complete remission of advanced ovarian epithelial carcinoma: a long-term survival analysis. Int J Gynecol Cancer 14: 794–8

    Article  CAS  PubMed  Google Scholar 

Download references

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer-Verlag France

About this chapter

Cite this chapter

Thomas, L. (2006). La radiothérapie dans les cancers ovariens. In: Les cancers ovariens. Abord clinique. Springer, Paris. https://doi.org/10.1007/2-287-30921-7_26

Download citation

  • DOI: https://doi.org/10.1007/2-287-30921-7_26

  • Publisher Name: Springer, Paris

  • Print ISBN: 978-2-287-25168-9

  • Online ISBN: 978-2-287-30921-2

Publish with us

Policies and ethics